Altamira Therapeutics Ltd.(CYTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CYTO Altamira Therapeutics Ltd.

Delisted 12-11 14:17:15 EST

0.3000

+0.0000

0.00%

High0.3000	Low0.3000	Vol0.00
Open0.3000	D1 Closing0.3000	Amplitude0.00%
Mkt Cap1.13M	Tradable Cap1.13M	Total Shares3.78M
T/O0.00	T/O Rate0.00%	Tradable Shares3.76M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CYTO","market":"US","secType":"STK","nameCN":"Altamira Therapeutics Ltd.","latestPrice":0.3,"timestamp":1765480635395,"preClose":0.3,"halted":4,"volume":0,"delay":0,"floatShares":3757799,"shares":3778500,"eps":-1.906544,"marketStatus":"Delisted","change":0,"latestTime":"12-11 14:17:15 EST","open":0.3,"high":0.3,"low":0.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.906544,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"listingDate":1407297600000,"exchange":"NASDAQ","adjPreClose":0.3,"volumeRatio":0},"requestUrl":"/m/hq/s/CYTO","defaultTab":"news","newsList":[{"id":"2492482894","title":"BRIEF-Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2492482894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492482894?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:10","pubTimestamp":1734700226,"startTime":"0","endTime":"0","summary":"BRIEF-Altamira Therapeutics Announces Transition From Nasdaq To OTC MarketsDec 20 (Reuters) - Altamira Therapeutics Ltd CYTO.O:ALTAMIRA THERAPEUTICS ANNOUNCES TRANSITION FROM NASDAQ TO OTC MARKETSALTA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CYTO"],"gpt_icon":0},{"id":"2492448848","title":"Altamira Therapeutics Ltd: No Reverse Stock Split Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492448848?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:00","pubTimestamp":1734699611,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL0D4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CYTO"],"gpt_icon":0},{"id":"2492744884","title":"Altamira Therapeutics Ltd - Shares to Trade on Otcqb Under Ticker Cytof","url":"https://stock-news.laohu8.com/highlight/detail?id=2492744884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492744884?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:00","pubTimestamp":1734699601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA8WJ66P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BKPKM429.USD","CYTO","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","BK4588","BK4112","LU2210150020.SGD","BK4007","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585"],"gpt_icon":0},{"id":"2492100484","title":"Altamira Therapeutics Announces Transition From Nasdaq to Otc Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2492100484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492100484?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:00","pubTimestamp":1734699601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA8WJ66P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210150020.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","CYTO","NDAQ","BK4588","LU2095319765.USD","IE00B3QW5Z07.USD","BK4007","BK4585","IE00BKPKM429.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altamiratherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.3475},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and supplies OligoPhore/SemaPhore platforms, which are peptide-based nanoparticle technologies for ribonucleic acid delivery to extrahepatic tissues. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, which is in phase II/III clinical trial for the treatment of acute inner ear tinnitus; and Sonsuvi that is in phase III of clinical development for the treatment of acute inner ear hearing loss. It also offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.162342},{"month":2,"riseRate":0.4,"avgChangeRate":-0.072173},{"month":3,"riseRate":0.4,"avgChangeRate":-0.102052},{"month":4,"riseRate":0.3,"avgChangeRate":-0.108847},{"month":5,"riseRate":0.2,"avgChangeRate":-0.119034},{"month":6,"riseRate":0.3,"avgChangeRate":-0.081277},{"month":7,"riseRate":0.4,"avgChangeRate":-0.110698},{"month":8,"riseRate":0.1,"avgChangeRate":-0.137249},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.097551},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.066794},{"month":11,"riseRate":0.363636,"avgChangeRate":0.112711},{"month":12,"riseRate":0.454545,"avgChangeRate":0.062136}],"exchange":"NASDAQ","name":"Altamira Therapeutics Ltd.","nameEN":"Altamira Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altamira Therapeutics Ltd.(CYTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Altamira Therapeutics Ltd.(CYTO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Altamira Therapeutics Ltd.,CYTO,Altamira Therapeutics Ltd.股票,Altamira Therapeutics Ltd.股票老虎,Altamira Therapeutics Ltd.股票老虎国际,Altamira Therapeutics Ltd.行情,Altamira Therapeutics Ltd.股票行情,Altamira Therapeutics Ltd.股价,Altamira Therapeutics Ltd.股市,Altamira Therapeutics Ltd.股票价格,Altamira Therapeutics Ltd.股票交易,Altamira Therapeutics Ltd.股票购买,Altamira Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altamira Therapeutics Ltd.(CYTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Altamira Therapeutics Ltd.(CYTO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction